New Challenge For Acthar Is Labeling; Practitioners Disagree On Dosing

Having gathered an advisory committee's endorsement that Questcor Pharmaceutical's Acthar (corticotropin) is effective for treating infantile spasms - a common off-label use - the remaining challenge for FDA is determining how the drug should be used in that indication